Case studies to explore the pitfalls in the diagnosis of sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 23, Issue 2, 2006, Pages 135-140

  Schilstra, Alexandra ^a   Rottoli, Paola ^b   Jacobs, Jan A ^c,e   Van Suylen, Robert Jan ^c,e   Galluzzi, Paola ^d   Drent, Marjolein ^a,c,e  

^a University Hospital

^b UNIVERSITY OF SIENA   (Italy)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

^e Sarcoidosis Management Team Maastricht ^*

Author keywords

Granulomatous infections; Leishmania; Lyme disease; Sarcoidosis; Whipple's disease

Indexed keywords

AMINOGLYCOSIDE; CORTICOSTEROID; COTRIMOXAZOLE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE PREDISPOSITION; GRANULOMATOSIS; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SARCOIDOSIS; X RAY ANALYSIS;

ADULT; ANIMALS; BIOPSY; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; DNA, PROTOZOAN; HUMANS; LEISHMANIA; LEISHMANIASIS; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED; WHIPPLE DISEASE;

EID: 34748902076     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Yamamoto M, Sharma OP, Hosoda Y: Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis 1992; 9; 33-4.
2. Zumla A, Geraint James D: Granulomatous infections : an overview. The granulomatous disorders. Cambridge University Press 1999: 103-21.
3. Gerold S, Franc S: Lyme borreliosis. The Lancet 2003; 362: 1639-47.
4. Judson MA, Bauchman RP, Thompson BW, et al: Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-11.
5. Nagai S, Izumi T: Pulmonary sarcoidosis: population differences and pathophysiology. South Med J 1995; 88: 1001-10.
6. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
7. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PGH, Drent M: Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clinical Chem 2003; 49: 1510-7.
8. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JMM, van Velzen-Blad H: Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis. Chest 2003; 124: 186-95.
9. Du Bois RM, Goh N, D. McGrath, Cullinan P: Is there a role for microorganisms in the pathogenesis of sarcoidosis? Journal of Internal medicine 2003; 253: 4-17.
10. Xu Z, Ma D, Luo W, Zhu Y: Detection of Borrelia burgdorferi DNA in grnulomatous tissues from patients with sarcoidosis using polymerase chain reaction in situ technique. Chin Med Sci J 1996; 11: 220-3.
11. Summers BA, Straubinger AF, Jacobson RB, Chang YF, Appel MJG, Straubinger RK: Histopathological studies of experimental Lyme disease in the dog. J Comp Path 2005; 133: 1-13.
12. Gravino AE: Interpretation of laboratory data during cryptic leishmaniasis in dog. Parassitologia 2004; 46; 227-9.
13. Dutly F, Altwegg M: Whipple's disease and Tropheryma whippelii. Clin Microbiol Rev 2001; 14: 561-83.
14. Riemer H, Hainz R, Stain Ch, et al: Severe pulmonary hypertension reversed by antibiotics in a patient with Whipple's disease. Thorax 1997; 52: 1014-5.
15. Morrison DA, Gay RG, Feldshon D, Sampliner RE: Severe pulmonary hypertension in a patient with Whipple's disease. Am J Med 1985; 79: 263-7.
16. Peschard S, Brinkane A, Bergheul S, et al: Whipple disease associated with pulmonary arterial hypertension. Jarisch-Herxheimer reaction after antibiotic therapy. Presse Med 2001; 30: 1549-51.
17. Sadikot RT, Dore P, Arnold AG: Sarcoidosis and opportunistic infections. South Med J 2001; 94: 75-7.
18. WASOG: Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-55.